CoChat

The DOI matches its Crossref record; 74 of the 75 references it cites were found in a registry or an index.

Optimal Strategies for Colorectal Cancer Screening

Open access
Jain, Shailavi, Maque, Jetrina, Galoosian, Artin, Osuna-Garcia, Antonia, May, Folasade P. · 2022 · Current Treatment Options in Oncology

Abstract

Opinion statement: Colorectal cancer (CRC) imposes significant morbidity and mortality, yet it is also largely preventable with evidence-based screening strategies. In May 2021, the US Preventive Services Task Force updated guidance, recommending screening begin at age 45 for average-risk individuals to reduce CRC incidence and mortality in the United States (US). The Task Force recommends screening with one of several screening strategies: high-sensitivity guaiac fecal occult blood test (HSgFOBT), fecal immunochemical test (FIT), multi-target stool DNA (mt-sDNA) test, computed tomographic (CT) colonography (virtual colonoscopy), flexible sigmoidoscopy, flexible sigmoidoscopy with FIT, or traditional colonoscopy. In addition to these recommended options, there are several emerging and novel CRC screening modalities that are not yet approved for first-line screening in average-risk individuals. These include blood-based screening or “liquid biopsy,” colon capsule endoscopy, urinary metabolomics, and stool-based microbiome testing for the detection of colorectal polyps and/or CRC. In order to maximize CRC screening uptake in the US, patients and providers should engage in informed decision-making about the benefits and limitations of recommended screening options to determine the most appropriate screening test. Factors to consider include the invasiveness of the test, test performance, screening interval, accessibility, and cost. In addition, health systems should have a programmatic approach to CRC screening, which may include evidence-based strategies such as patient education, provider education, mailed screening outreach, and/or patient navigation, to maximize screening participation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11864-022-00962-4

Cites

74 of 74 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 74 references

Research works printed but not linked: 1

  1. Kaur K, Adamski JJ. Fecal Occult Blood Test. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2021, StatPearls Publishing LLC; 2021.

Cited by

See all 111

Metadata

Authors
Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A., & May, F. P.
Affiliations
  • University of California, Los Angeles (US)
  • Kaiser Permanente (US)
Corresponding author
May, Folasade P.
Venue
Current Treatment Options in Oncology
Published
2022-03-22
Volume
23
Issue
4
Pages
474-493
ISSN
  • 1527-2729 (ISSN-L)
  • 1534-6277
OpenAlex
W4221111564
Cited by
110
References
75
Citations by year
2026: 20 · 2025: 35 · 2024: 29 · 2023: 23 · 2022: 3
FWCI
2.78
Type
journal article
Language
en
Open access
Licence
Locations
  • Current Treatment Options in Oncology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
Jonsson Comprehensive Cancer Center
Topics
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Screening and Detection
  • Health Sciences › Medicine › Oncology › Colorectal Cancer Surgical Treatments
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
Keywords
colorectal cancer screening, colorectal cancer prevention, USPSTF screening recommendations, average-risk population, fecal immunochemical test, multi-target stool DNA test, CT colonography, flexible sigmoidoscopy, colonoscopy, liquid biopsy, colon capsule endoscopy, urine metabolomics, colorectal polyps, screening uptake, patient navigation, screening outreach, informed decision-making
MeSH terms
Colonoscopy, Humans, Mass Screening, Middle Aged, Occult Blood, Sigmoidoscopy, United States, Colorectal Neoplasms, Early Detection of Cancer

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Optimal Strategies for Colorectal Cancer Screening. https://app.cochat.ai/papers/10.1007/s11864-022-00962-4
The paper
Jain, S., Maque, J., Galoosian, A., Osuna-Garcia, A., & May, F. P. (2022). Optimal Strategies for Colorectal Cancer Screening. Current Treatment Options in Oncology. https://doi.org/10.1007/s11864-022-00962-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.